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ABSTRACT 18 
 19 
We have developed a high-throughput sequencing (HTS) workflow for investigating 20 
paramyxovirus transcription and replication. We show that sequencing of oligo-dT 21 
selected polyadenylated mRNAs, without considering the orientation of the RNAs 22 
from which they had been generated, cannot accurately be used to analyse the 23 
abundance of viral mRNAs because genomic RNA co-purifies with the viral mRNAs. 24 
The best method is directional sequencing of infected cell RNA that has physically 25 
been depletion of ribosomal and mitochondrial RNA followed by bioinformatic steps 26 
to differentiate data originating from genomes from viral mRNAs and antigenomes. 27 
This approach has the advantage that the abundance of viral mRNA (and 28 
antigenomes) and genomes can be analysed and quantified from the same data. We 29 
investigated the kinetics of viral transcription and replication during infection of A549 30 
cells with parainfluenza virus type 2 (PIV2), PIV3, PIV5 or mumps virus, and 31 
determined the abundance of individual viral mRNAs and readthrough mRNAs. We 32 
found that the mRNA abundance gradients differed significantly between all four 33 
viruses, but that for each virus the pattern remained relatively stable throughout 34 
infection. We suggest that rapid degradation of nonpolyadenylated mRNAs may be 35 
primarily responsible for the shape of the mRNA abundance gradient in 36 
parainfluenza virus 3, whereas a combination of this factor and disengagement of 37 
RNA polymerase at intergenic sequences, particularly those at the NP:P and P:M 38 
gene boundaries, may be responsible in the other viruses. 39 
 40 
Importance 41 
 3
High throughput sequencing (HTS) of virus infected cells can be used to study in 42 
great detail the patterns of virus transcription and replication. For paramyxoviruses, 43 
and by analogy for all other negative strand RNA viruses, we show that directional 44 
sequencing must be used to distinguish between genomic RNA and 45 
mRNA/antigenomic RNA because significant amounts of genomic RNA co-purify 46 
with polyA-selected mRNA. We found that the best method is directional sequencing 47 
of total cell RNA, after the physical removal of ribosomal RNA (and mitochondrial 48 
RNA), because quantitative information on the abundance of both genomic RNA and 49 
mRNA/antigenomes can be simultaneous derived. Using this approach, we reveal 50 
new details of the kinetics of virus transcription and replication for parainfluenza virus 51 
(PIV) type 2, PIV3, PIV5 and mumps virus, as well as on the relative abundance of 52 
the individual viral mRNAs. 53 
  54 
 4
INTRODUCTION 55 
 56 
The family Paramyxoviridae belongs to the order Mononegavirales and is populated 57 
by a large number of vertebrate viruses, some of which cause diseases in humans, 58 
including mumps, measles and respiratory infections 59 
(https://talk.ictvonline.org/taxonomy/). Parainfluenza virus 2 (PIV2), parainfluenza 60 
virus 5 (PIV5) and mumps virus (MuV) are members of species Human 61 
orthorubulavirus 2, Mammalian orthorubulavirus 5 and Mumps orthorubulavirus, 62 
respectively, in genus Orthorubulavirus of subfamily Rubulavirinae. Parainfluenza 63 
virus 3 (PIV3) is a member of species Human respirovirus 3 in genus Respirovirus of 64 
subfamily Orthoparamyxovirinae; measles virus is a member of species Measles 65 
morbillivirus in genus Morbillivirus of the same subfamily. 66 
 67 
Paramyxoviruses possess single-stranded, non-segmented, negative-sense RNA 68 
genomes that are typically 15,000-19,000 nucleotides (nt) in size. The genomes of 69 
different paramyxoviruses encode comparable, but not identical, cohorts of genes 70 
that exhibit largely analogous functions (see Figure 1 for the layout in PIV5). The 3’ 71 
end of the genome contains an extracistronic region of 55-70 nt, which makes up the 72 
leader (Le) region and contains the Le promoter elements required for generation of 73 
viral mRNAs and antigenomes. The first promoter element is a conserved string of 74 
approximately 13 nucleotides at the 3’ end of the genome, the second element is 75 
tandem repeats in the untranslated region of the NP gene. These repeats must be in 76 
the correct position in relation to their encapsidating NP monomer known as 77 
hexamer phase. The 5’ end of the genome contains an extracistronic region of 21-78 
161 nt that is known as the trailer (Tr) region. Viral mRNAs are transcribed by a stop-79 
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start process that is directed by cis-acting elements in the genome. These elements 80 
include the gene start (GS) and gene end (GE) sites that flank the individual genes. 81 
Immediately downstream of the GE site is a polyU-tract of variable length, which 82 
forms the site of mRNA polyadenylation. Between each pair of genes there is an 83 
additional cis-acting element known as the intergenic (IG) region, which consists of a 84 
short sequence (1-56 nt) that is not generally transcribed into mRNA. IG regions vary 85 
in sequence and length among paramyxovirus genera. Respiroviruses and 86 
morbilliviruses have IG regions that are conserved in length and sequence within the 87 
genome, whereas rubulaviruses possess IG regions that vary in length and 88 
sequence throughout the genome (for reviews of the molecular biology of 89 
paramyxoviruses see (1, 2). 90 
 91 
The processes of transcription and replication are similar in members of the order 92 
Mononegavirales (3). Upon entry of the virus into the cell, primary transcription of 93 
genomes to generate mRNAs is initiated by the virion-associated viral RNA-94 
dependent RNA polymerase complex (vRdRP), which, in the case of 95 
paramyxoviruses, consists of the large protein (L) and the phosphoprotein (P). Only 96 
after sufficient amounts of soluble NP (NP0), which is kept soluble by its interaction 97 
with the N-terminal common domain of P and V (4-7), has been produced does virus 98 
replication begin as NP0 is required for encapsidation of newly synthesized genomes 99 
and antigenomes (8, 9). The new viral genomes then act as templates for secondary 100 
transcription and replication.  101 
 102 
During transcription, vRdRP attaches to the Le promoter and scans along the 103 
genome until it reaches the first GS site, where it initiates transcription of the NP 104 
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gene. The GS site is thought to contain the signal for vRdRP to carry out capping 105 
and cap methylation (10-12). After transcription of the NP gene, polyadenylation 106 
occurs by stuttering of vRdRP in the 4-7 U residues following the GE site. An mRNA 107 
that is 5’-capped and methylated and 3’-polyadenylated is then released. The 108 
generally accepted model is that vRdRP then either disengages from the genome at 109 
the GE or it traverses the IG region to reinitiate transcription at the GS site of the 110 
next gene. If vRdRP disengages from the genome, it can only participate in further 111 
transcription by reinitiating transcription at the Le promoter. This mechanism, known 112 
as stop-start transcription, produces a transcriptional gradient, with greater quantities 113 
of mRNA being produced from genes nearer the 3’ end of the genome (13-16). With 114 
time post infection (p.i.) not only will the rate of production of individual viral mRNAs 115 
determine their relative abundance, but also their relative rate of degradation. 116 
Throughout the manuscript we therefore refer to mRNA abundance gradients rather 117 
than transcriptional gradients. During transcription, vRdRP sometimes fails to 118 
terminate transcription at the GE site. When this happens, vRdRP transcribes the IG 119 
region and downstream gene(s), producing a polycistronic or readthrough mRNA. A 120 
shared characteristic of paramyxovirus transcription is a higher rate of readthrough 121 
at the M:F boundary. The mechanism that directs the rates of readthrough at the 122 
gene junctions is unclear. A series of papers by Rassa and Parks (17-19) identified 123 
the GE site and the first nucleotide of the IG region to be important in generating a 124 
greater abundance of M:F readthrough mRNA and suggested that these elements 125 
may work in tandem to direct the vRdRP. Unlike Vesicular stomatis virus (VSV) of 126 
the order Mononegavirales from the rhabdoviridae family that are thought to have 127 
similar transcription and replication mechanisms, altering the length of the IG region 128 
did not effect the frequency of M-F mRNA read-throughs. Furthermore, these papers 129 
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suggested that the U-tract and IG region might act as a spacer between the GE and 130 
GS sites and play an important role in transcriptional initiation at the next gene (19).  131 
 132 
Paramyxoviruses share the common feature of allowing multiple mRNAs to be 133 
transcribed from the P/V gene by a process known as RNA editing. This is where 134 
additional G residues are inserted at a specific position in a proportion of mRNAs, 135 
facilitating a translational frameshift. RNA editing occurs by slippage of vRdRP within 136 
a short polyG tract, in a manner similar to that occurring during polyadenylation (20, 137 
21). In orthorubulaviruses, the V/P gene produces three transcripts: V, which is a 138 
faithful copy of the gene; P, which is generated by insertion of two G residues at the 139 
RNA editing site of the P transcript; and I, which is produced by insertion of a single 140 
G residue. As a result, the V, P and I proteins share the same N-terminal sequence 141 
but differ in their C-terminal sequences. In respiroviruses, P is a faithful copy of the 142 
gene, and mRNAs encoding D and V are generated by insertion of one or two G 143 
residues, respectively. A number of paramyxoviruses also produce one or more C 144 
proteins from an additional open reading frame (ORF) present upstream of the RNA 145 
editing site that generates the P, D and V mRNAs. 146 
 147 
During replication the vRdRP attaches to the Le promoter and transcribes the entire 148 
genome, ignoring all GS and GE sites. This produces a full-length, faithful, positive-149 
sense copy of the genome known as the antigenome, which acts as a template for 150 
production of viral genomes. The complement of the Tr region, the 3’ end of the 151 
antigenome, contains the antigenome promoter (TrC) elements required for RdRp 152 
polymerase recognition and initiation of the production of de novo genomes. The 153 
newly synthesized genomes and antigenomes are concurrently encapsidated by NP0 154 
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to form the nucleocapsid structure. It is thought that concurrent replication and 155 
encapsidation allow vRdRP to ignore GS and GE sites (22, 23). 156 
 157 
Despite this general understanding of the general patterns of paramyxovirus 158 
transcription and replication, detailed descriptions are lacking for most individual 159 
paramyxoviruses. In the present study, we exploited high-throughput sequencing 160 
(HTS) to analyse simultaneously the kinetics of transcription and replication of 161 
several paramyxoviruses, thus potentially also shedding light on these processes in 162 
all members of the order Mononegavirales.  163 
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MATERIALS AND METHODS 164 
 165 
Infections 166 
 167 
Human skin fibroblast (HSF) and A549 cells (of human adenocarcinomic alveolar 168 
basal epithelial origin) were maintained as monolayers in 25 cm2 tissue culture flasks 169 
(Greiner) in Dulbecco’s modified Eagles’s medium (Invitrogen) supplemented with 170 
10% (v/v) heat-inactivated foetal bovine serum (Biowest) and incubated in 5% (v/v) 171 
CO2 at 37°C. The viruses used were PIV2 strain Colindale (PIV2-Co), PIV3 strain 172 
Washington/47885/57 (PIV3-Wash (24)), PIV5 strain W3 (PIV5-W3 (25)), MuV strain 173 
Enders (MuV-Enders (26)), PIV5 strain CPI+ (PIV5-CPI+ (27)) and PIV5 strain 174 
rPIV5-W3:P(F157 (28)). Cell monolayers were infected with virus diluted in medium 175 
at a multiplicity of infection (MOI) of 10-20 plaque-forming units (PFU) per cell, 176 
unless stated otherwise. The infected monolayers were placed on a rocker for 1 h to 177 
allow adsorption of the virus, after which the inoculum was removed and replaced 178 
with medium supplemented with 10% (v/v) heat-inactivated foetal bovine serum and 179 
incubated in 5% (v/v) CO2 at 37°C until harvested.  180 
 181 
DNA sequencing 182 
 183 
Cells were scraped into the medium and transferred into 15 ml tubes which were 184 
centrifuged at 4700 rpm for 5 min. The pellet was resuspended in 1 ml Trizol 185 
(Invitrogen), and an equal volume of ethanol was added. RNA was isolated using a 186 
Direct-zol RNA miniprep kit (Zymo) and sequenced directionally, either by selection 187 
of polyadenylated (polyA) mRNA using a TruSeq stranded mRNA library preparation 188 
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kit LS (Illumina) or by reduction of rRNA or rRNA plus mitochondrial RNA using a 189 
TruSeq stranded total RNA library preparation kit with a Ribo-Zero human/mouse/rat 190 
kit (Illumina) or a Ribo-Zero Gold kit LS (Illumina), respectively. Identical steps for 191 
library preparation were then followed (for a full description see 192 
https://support.illumina.com). Quality control and quantification of DNA libraries were 193 
monitored using a 2100 Bioanalyzer with DNA-specific 1000 or 5000 chips (Agilent) 194 
and a Qubit fluorometer (Invitrogen). The libraries were normalized to 10 nM, pooled 195 
in equal volumes, and subjected to HTS on MiSeq or NextSeq instruments (Illumina) 196 
to produce paired-end reads in two files (R1 and R2) that contained data obtained 197 
with the forward and reverse primers. 198 
 199 
Bioinformatic analyses 200 
 201 
The sequencing data were demultiplexed, and the reads were trimmed to remove 202 
adapter sequences and filtered to remove low quality reads using TrimGalore 203 
(available at https://github.com/FelixKrueger/TrimGalore). Read quality (Q score) 204 
was restricted to >30. 205 
 206 
A bioinformatic pipeline was developed for analysing viral transcription and 207 
replication. The reads contained in the R1 and R2 files were mapped independently 208 
to the appropriate reference genome sequence using BWA version 0.7.5a-r405 (29). 209 
The reference genomes for PIV2-Co, PIV5-W3, PIV5-CPI+ and MuV-Enders were 210 
obtained from GenBank (accession nos. AF533012, JQ743318, JQ743321 and 211 
GU980052, respectively). The PIV3-Wash sequence was obtained by de novo 212 
assembly of the read data. The aligned reads were then binned from the R1 and R2 213 
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assemblies on the basis of their orientation in relation to the genome sequence, and 214 
combined to produce two files exclusively containing genome or mRNA/antigenome 215 
reads. The reads in these files were then mapped independently to the reference 216 
sequence using BWA. The number of reads mapping to the genome and their 217 
coverage depth across the genome were ascertained by visualising these 218 
alignments using Tablet version 1.15.09.01 (30). In later stages of the study, the 219 
abundances of genome and mRNA/antigenome reads were calculated relative to 220 
total read numbers (including cellular reads) from which residual rRNA and 221 
mitochondrial RNA reads had been removed. The latter reads were identified by 222 
aligning the trimmed, filtered data to reference genomes for human 18S, 28S, 5S 223 
and 5.8S rRNA and mitochondrial DNA (accession numbers NR_003286.2, 224 
NR_003287, X51545, J01866 and NC_012920, respectively).  225 
 226 
Relative mRNA abundances were calculated from fragments per kilobase of 227 
transcript per million mapped reads (FPKM) values obtained using RSEM version 228 
1.3.0 (31). FPKM values normalise the abundance of transcripts generated from 229 
individual genes to account for differences in gene length, thus allowing the relative 230 
amounts of viral mRNA generated from different genes to be compared. However, 231 
this method cannot distinguish between alternative transcripts generated by RNA 232 
editing. Instead, reads overlapping the RNA editing site were quantified by identifying 233 
those containing the 10 nt sequences immediately upstream and downstream of the 234 
polyG tract in which editing occurs, which contains a tract of  G residues. The 235 
numbers of these reads containing 1, 2, 3, 4, 5, 6 or 7 additional G residues were 236 
binned individually and compared to the total. 237 
 238 
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To quantify reads that cross IG regions, the average coverage depth of reads that 239 
align to specific genes or that cross the IG region was calculated using 240 
SAM2CONSENSUS version 2.0 (available at 241 
https://github.com/vbsreenu/Sam2Consensus). The proportion of readthrough 242 
mRNAs was calculated by comparing the number of reads that cross the IG region to 243 
the average coverage depth of the gene immediately upstream. 244 
 245 
  246 
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RESULTS 247 
 248 
Transcription and replication in PIV5 249 
 250 
In preliminary studies, untransformed HSF cells (that had only undergone limited 251 
passage in tissue culture cells) were infected with PIV5-W3 at an MOI of 50 252 
PFU/cell. RNA was extracted at 18 h post-infection (p.i.), and mRNA was isolated by 253 
polyA selection prior to HTS on the MiSeq platform. The resulting R1 and R2 files 254 
contained a total of 6,523,498 reads, which were trimmed and mapped to the PIV5-255 
W3 genome sequence without considering the orientation of the RNAs from which 256 
they had been generated. Viral reads accounted for 4.7% of the total. Coverage 257 
depth of the NP and V/P genes was greater than that of other genes, reflecting the 258 
anticipated mRNA abundance gradient (Figure 1a, top panel). However, downstream 259 
genes, including the L gene, displayed approximately equivalent coverage depth, 260 
implying that the gradient did not extend to these genes. An alternative explanation 261 
was that the polyA-selected RNA preparation contained significant amounts of 262 
genomes and antigenomes. To determine whether this was the case, the orientation 263 
of the original RNAs (viral genomes are negative-sense and viral 264 
mRNAs/antigenomes are positive-sense) was considered by mapping the genome 265 
and mRNA/antigenome reads independently to the PIV5-W3 sequence (Figure 1a, 266 
middle and bottom panels). Although mRNA/antigenome reads accounted for 2.2% 267 
of total reads, genome reads accounted for more (2.5%), showing that significant 268 
amounts of genome RNA were present in the polyA-selected RNA preparation. 269 
Alignment of mRNA/antigenome reads revealed a clear mRNA abundance gradient, 270 
with greater coverage depth in genes at the 3’ end of the genome (NP and V/P) and 271 
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significantly less coverage depth in the L gene at the 5’ end (Figure 1a, bottom 272 
panel). Although it is not possible to distinguish reads generated from mRNAs from 273 
those generated from antigenomes by directional sequencing, the proportion of 274 
antigenome reads cannot exceed that of the L gene extended over the whole 275 
genome (2.6% of mRNA/antigenome reads overall). Finally, by calculating the 276 
average coverage depth of reads at positions 45-54 in the Le region (which is not 277 
included in mRNAs), it was estimated that antigenomes contributed only 0.05% of 278 
mRNA/antigenome reads.  279 
 280 
Although viral genomes co-purified with mRNA during polyA selection most likely 281 
due to hybridization of complementary RNA during RNA extraction, the number of 282 
viral genomes in infected cells could not be quantified because the efficiency of 283 
selection was not known. Therefore, we investigated whether directional sequencing 284 
following depletion of rRNA, rather than polyA selection, could achieve the 285 
quantification of both genome and mRNA/antigenome RNA from the same dataset. 286 
A549 cells were infected with PIV5-W3 at an MOI of 10 PFU/cell. RNA was extracted 287 
at 6, 12 and 18 h p.i. and subjected to rRNA reduction or polyA selection prior to 288 
HTS on the MiSeq platform. The resulting R1 and R2 files were processed into 289 
genome and mRNA/antigenome files and mapped to the PIV5-W3 sequence. Since 290 
neither polyA selection nor depletion of rRNA was capable of completely removing 291 
rRNA from the samples, and also did not remove mitochondrial RNA, residual rRNA 292 
and mitochondrial reads were removed bioinformatically from this point (Table 1). 293 
The abundance of mitochondrial RNA reads was particularly apparent in the rRNA 294 
reduction approach and indicated that a physical method that reduces both rRNA 295 
and mitochondrial RNA prior to sequencing may, under certain circumstances be the 296 
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most appropriate method to use. 297 
 298 
No significant differences were observed between polyA selection and rRNA 299 
reduction in terms of either relative mRNA abundance or the shape of the mRNA 300 
abundance gradient (Figure 1b and c; a quantitative description of the mRNA 301 
abundance gradient is provided below). For example, the observation that the mRNA 302 
profile at 12 h p.i. for polyA-selected RNA was essentially indistinguishable from that 303 
for rRNA-depleted RNA (Figure 1b) indicated that directional sequencing of total 304 
infected cell RNA, incorporating both physical and bioinformatic removal of rRNA 305 
reads (and bioinformatic removal of mitochondrial RNA reads), can be used to 306 
investigate the mRNA abundance gradient of PIV5, and thus potentially of all 307 
negative-strand RNA viruses. The advantage of rRNA reduction over polyA selection 308 
is that it facilitates quantification of the abundance of both genome and 309 
mRNA/antigenome reads in the same dataset (Figure 1c). Indeed, the amount of 310 
viral genomes present in polyA-selected RNA proved to be significantly less than 311 
that in rRNA-reduced RNA, presumably because not all genomes co-purified with 312 
mRNA during polyA selection. The abundance of genome reads determined from 313 
rRNA reduction data increased gradually between 6 and 18 h p.i. from 0.09 to 1.42% 314 
of total reads. Interestingly, a gradient of genome reads from the Tr region was 315 
visualised at 12 h p.i. (Figure 1b), perhaps because incomplete replicating genomic 316 
RNA had been sequenced. Additionally, the proportion of antigenomes at 6, 12 and 317 
18 h p.i. was estimated from coverage at positions 45-54 that was extended to the 318 
whole genome and was estimated as 0.07, 0.21 and 0.16%, respectively, of total 319 
reads. In addition, to quantify the amount of genomic RNA present, sequencing of 320 
total infected cell RNA also facilitates the detection and quantification of defective 321 
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interferring genomes (28).  322 
 323 
The analysis described above involved physical reduction of rRNA. However, a 324 
significant proportion of reads originated from mitochondrial RNA (Table 1). All 325 
subsequent experiments were conducted using physical reduction of rRNA and 326 
mitochondrial RNA followed by bioinformatic removal of residual rRNA and 327 
mitochondrial RNA reads. In addition, all subsequent samples were sequenced using 328 
the NextSeq, rather than MiSeq, platform, in order to generate more reads. Following 329 
sequencing, the bioinformatic pipeline described above was key to the analysis, as it 330 
allowed genome and mRNA/antigenome reads to be distinguished from each other. 331 
 332 
Analysis of transcription and replication in other paramyxoviruses 333 
 334 
The workflow described above was used to investigate and compare the rate of viral 335 
mRNA and genome accumulation of PIV2-Co, PIV3-Wash, PIV5-W3 and MuV-336 
Enders. Triplicate cultures of A549 cells were infected with the individual viruses at 337 
an MOI of 10-20 PFU/cell. Total infected cell RNA was isolated at 0, 6, 12, 18 and 24 338 
h p.i. and processed for sequencing and subsequent bioinformatic analysis (Figure 339 
2). Since we had estimated that antigenome reads form a very small proportion of 340 
mRNA/antigenome reads, we have abbreviated below mRNA/antigenome reads to 341 
just mRNA reads where appropriate. 342 
 343 
PIV3-Wash exhibited significantly faster transcriptional kinetics than the other 344 
viruses, with mRNA contributing approximately 10% of total RNA at 6 h p.i. and 345 
reaching maximal levels (approximately 18%) by 12 h p.i. In contrast, the levels of 346 
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PIV2-Co, PIV5-W3 and MuV-Enders transcripts were <2% of total RNA at 6 h p.i. 347 
The greatest increase in the rate of viral transcription for PIV2-Co, PIV5-W3 and 348 
MuV-Enders was observed between 6 and 12 h p.i. However, the pattern of PIV5-349 
W3 transcription differed significantly at later times from that of MuV-Enders and 350 
PIV2-Co, with mRNA levels peaking at 16-19% of total RNA at 18 and 24 h p.i., 351 
respectively. In contrast, the levels of PIV5-W3 mRNA peaked between 12 and 18 h 352 
p.i., contributing 4-5% of total RNA, after which the abundance decreased to 2-3% 353 
by 24 h p.i. This reflects an almost fourfold difference in peak mRNA abundance 354 
between PIV5-W3 and PIV2-Co and MuV-Enders (discussed further below). Despite 355 
differences in the kinetics of transcription and relative abundance of the PIV2-Co, 356 
PIV5-W3 and MuV-Enders mRNAs, the abundance of viral genomes gradually 357 
increased for all three viruses between 6 and 24 h p.i. from approximately 0.03 to 1-358 
2% of total RNA. As would be expected from the faster rate of transcription in PIV3-359 
Wash, replication was also slightly faster, with a significant increase in viral genome 360 
numbers being observed between 6 and 12 h p.i., reaching maximal levels by 18 h 361 
p.i. 362 
 363 
Viral mRNA abundance gradients 364 
 365 
The viral mRNA abundance gradients were analysed in the above samples by 366 
determining the relative abundance of individual viral mRNAs using FPKM values, 367 
which take into account gene length in order to allow the relative amounts of mRNA 368 
transcribed from individual genes to be compared. These values were then used to 369 
determine the percentage contribution of each viral mRNA to the total (Figure 3). 370 
 371 
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There were significant differences between the transcriptional profiles of the four 372 
viruses. For PIV2-Co and PIV5-W3, the NP mRNAs were clearly the most abundant, 373 
contributing >45% of total mRNA in the case of PIV2-Co. There was then a relatively 374 
steep reduction in the abundance of the V/P mRNAs and then a more gradual 375 
decline until the HN mRNA, followed by a sharp decline in the abundance of L 376 
mRNA, particularly for PIV3 and PIV5. In contrast, the relative levels of the NP and 377 
V/P mRNAs were similar for MuV-Enders, with a relatively steep reduction to the M 378 
mRNA. For PIV3-Wash, there was a more gradual decline until the sharp decrease 379 
in the abundance of the L mRNA. Unexpectedly, although not open to meaningful 380 
statistical analysis, the relative abundance of the PIV3-Wash P/V/D mRNAs in most 381 
samples appeared to be slightly less than that of the M mRNA. Assuming that there 382 
is no internal entry site for vRdRP, this may reflect differences in mRNA stability. 383 
This may also explain the slight apparent differences observed in the mRNA 384 
abundance gradients for each virus at different time points. However, the fact that 385 
the transcriptional profiles at later time points were similar to those at 6h p.i., a time 386 
when the relative stability of different viral mRNAs are unlike to significantly effect the 387 
mRNA abundance gradients, suggests that there is no significant temporal control of 388 
the levels of viral transcription of individual genes.  389 
 390 
RNA editing 391 
 392 
The distribution of additional G residues inserted at the editing site into the relevant 393 
mRNAs is shown in Table 2. The editing profiles of PIV2-Co and PIV5-W3 were 394 
similar to each other (Figure 4). The ratio of V (unedited) to P (edited) mRNA was 395 
approximately 2:1 and 3:1, respectively. Together these mRNAs accounted for 396 
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approximately 98% of reads overlapping the editing site in PIV2-Co and 94% in 397 
PIV5-W3, with the I (edited) mRNA accounted for <2% of reads. Edited mRNAs with 398 
>2 G inserted residues contributed <1% and <3% of the total V/P/I mRNA population 399 
for PIV2-Co and PIV5-W3, respectively (Table 2). In contrast to the other 400 
orthorubulaviruses, the V (unedited) mRNA for MuV-Enders was only slightly more 401 
abundant than P (edited) mRNA, and I (edited) mRNA was 5% of the total V/P/I 402 
mRNA population (Figure 4). Furthermore, editing was less precise for MuV-Enders 403 
than PIV2-Co and PIV5-W3, in that the number of mRNAs with 3 and 4 inserted G 404 
residues amounted to approximately 8-9% of reads overlapping the editing site 405 
(Table 2). For PIV3-Wash, the P, D and V mRNAs were present at a ratio of 406 
approximately 3:2:1 (Figure 4). This result is in contrast to that observed by (32), 407 
who reported that PIV3 inserts from 1-6 G residues at the editing site with equal 408 
frequency. 409 
 410 
Readthrough mRNAs 411 
 412 
The generation of readthrough mRNAs has been proposed as a secondary 413 
mechanism by which paramyxoviruses control the level of production of viral proteins 414 
because translation of genes beyond the first represented in the mRNA will not 415 
occur. Readthrough mRNAs are generated when vRdRP fails to terminate 416 
transcription at a GE site and continues transcribing the IG region and subsequent 417 
gene(s) to produce a bi- (or poly-) cistronic mRNA. The generation of readthrough 418 
mRNAs was analysed by calculating the average coverage depth of reads 419 
overlapping each IG region and comparing it to the average coverage depth of reads 420 
of the gene immediately upstream (Figure 5). This method cannot, in principle, 421 
 20
distinguish readthrough mRNA from antigenomes but, for the reasons discussed 422 
above, the proportion of antigenomes compared to the total viral mRNA was 423 
assessed as being very low. In addition, the maximal contribution of antigenomes 424 
could not exceed the lowest read-through rate, which occurred sharply at the 425 
boundary between the HN and L genes in all four viruses. Moreover, the contribution 426 
of antigenomes would not explain any differences in readthrough transcription at the 427 
various gene boundaries. This method also cannot distinguish between bi- or poly- 428 
cistronic mRNAs which have been shown to be generated in PIV5 and MuV (33). 429 
The efficiency of readthrough transcription differed greatly among IG regions and 430 
among viruses. Thus, a high level of readthrough occurred between at the M:F 431 
boundary in each case, but the levels differed, being ~ 30% for PIV5-W3 and MuV 432 
but 90% for PIV3-Wash and PIV2-Co. Readthrough at the F:SH boundary was ~ 2% 433 
for PIV5-W3, which is in sharp contrast to MuV-Enders, in which it was 434 
approximately 91%, slightly lower than the estimated 100% reported using northern 435 
blot analysis (34). Similarly, readthrough at the SH:HN boundary was ~30% for MuV-436 
Enders but ~ 10% for PIV5-W3 (PIV2 and PIV3 lack the SH gene). Significantly 437 
lower levels of mRNA readthroughs were observed at other gene boundaries for all 438 
viruses (Figure 5). 439 
 440 
Effects of PIV5 strain 441 
 442 
Single strains of PIV2, PIV3, PIV5 and MuV were used in the analysis described 443 
above. To investigate whether strain differences influence the patterns of 444 
paramyxovirus transcription and replication, we analysed the mRNA abundance 445 
gradient, RNA editing and readthrough mRNA profiles of PIV5-CPI+ (Figure 6). In 446 
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comparison to PIV5-W3, maximal levels of PIV5-CPI+ transcription were significantly 447 
higher at later times (Figure 6a). Thus, approximately 18% of total RNA at 24 h p.i. 448 
was of viral mRNA origin in cells infected with PIV5-CPI+, compared to only 2-3% in 449 
cells infected with PIV5-W3. This is now known to be because PIV5-W3 (from now 450 
were appropriate is referred to as PIV5-W3(S157)) transcription is specifically 451 
repressed at late times in infection by phosphorylation of a serine residue at position 452 
157 in the P protein (28). Thus, in cells infected with recombinant virus rPIV5-453 
W3:P(F157), in which the serine residue at position 157 in PIV5-W3 was replaced by 454 
a phenylalanine residue, approximately 14% of total RNA was of viral origin at 24 h 455 
p.i. (Figure 7a). Similarly, PIV5-CPI+ has a phenylalanine residue at position 157 of 456 
the P protein that cannot be phosphorylated. However, initial rates of PIV5-CPI+ 457 
transcription were similar to those of PIV5-W3 and significantly lower than those of 458 
PIV3-Wash (compare Figures 3 and 6). However, there were also differences in the 459 
mRNA abundance gradient and readthrough mRNA profiles of PIV5-W3(S157) and 460 
PIV5-W3(F157) with that of PIV5-CPI+, but not in RNA editing (compare Figures 3 461 
and 6). In particular, there was a significantly greater dropoff in the abundance of 462 
P/V/I mRNAs compared to NP mRNA in cells infected with PIV5-CPI+ than in cells 463 
infected with PIV5-W3, and there was greater transcriptional readthrough at the 464 
M:SH junction in cells infected with PIV5-CPI+.  465 
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DISCUSSION 466 
 467 
Recently there have been several studies that quantified viral mRNAs using HTS for 468 
negative strand viruses such as Ebola, respiratory syncytial and Hendra viruses, e.g. 469 
see (35-39). For transcriptional studies employing HTS, mRNA from infected cells is 470 
typically isolated by polyA selection. Whilst directional sequencing of polyA-selected 471 
RNA and a bioinformatic protocol can be used to separate genome RNA data from 472 
mRNA/antigenome data, the method suffers from the disadvantage that high levels 473 
of quantifiable levels of genome RNA evidently co-purified with the polyA-selected 474 
mRNA, presumably as a consequence of RNA hybridisation. We therefore 475 
concluded that directional sequencing of total cell RNA following rRNA (and 476 
mitochondrial RNA) reduction was a better approach because it allowed the relative 477 
amounts of genome and mRNA/antigenome sequences to be quantified.  We have 478 
also published recently that sequencing total RNA following rRNA reduction can be 479 
used to detect and quantify defective virus genomes within infected cells without the 480 
need for nucleocapsid purification prior to sequencing (28). 481 
 482 
Separating mRNA and antigenome data is more problematic because these RNAs 483 
are both transcribed from genome templates. However, the contribution of 484 
antigenomes to the mRNA/antigenome signal is very small. Thus the levels of 485 
antigenome sequences cannot exceed the contribution of the L mRNA signal, which 486 
is very low in comparison with that of other genes. Estimates of antigenome 487 
abundance obtained by quantifying sequence reads of the region upstream of the 488 
GS site for the NP mRNA also strongly suggested that the contribution of antigome 489 
reads to the total mRNA/antigenome reads must be very small. However, these latter 490 
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estimates were only approximate because this region is small and located at the 3’ 491 
end of the genome, where coverage depth declines because during library 492 
preparation the sequenced fragments are selected to be of a certain minimal size. 493 
 494 
There were clear differences in both the kinetics of viral transcription and the mRNA 495 
abundance gradients between PIV2-Co, PIV3-Wash, PIV5-W3, PIV5-CPI+ and MuV-496 
Enders. PIV3-Wash replicated the fastest, with mRNAs contributing approximately 497 
10% of total RNA by 6 h p.i. In contrast, the kinetics of PIV2-Co, PIV5-W3, PIV5-498 
CPI+ and MuV-Enders were significantly slower, with viral mRNAs contributing <1% 499 
of total RNA at 6 h p.i., suggesting that there may be something fundamentally 500 
different between the mode of PIV3 (respirovirus) replication and that of PIV2, PIV5 501 
and MuV (orthorubulavirus) replication. It will be interesting to determine whether this 502 
holds for other viruses in these groups.  503 
 504 
The maximal amount of PIV5-W3 mRNA in infected cells was significantly lower than 505 
that of the other viruses examined. As discussed above, this is because PIV5-W3 506 
transcription and replication are repressed at late times in infection due to 507 
phosphorylation of a serine residue at position 157 on the P protein.  PIV5 508 
transcription is not repressed following infection with strains of PIV5, including PIV5-509 
CPI+ and rPIV5-W3:P(F157), that have a phenylalanine residue at position 157, and 510 
this is reflected in higher levels of viral mRNA at late times p.i. (28). Interestingly, 511 
although the relative levels of mRNA between PIV5-W3(S157) and PIV5-W3(F157) 512 
differ significantly at late times, the general pattern of their mRNA abundance 513 
gradients and the abundance of redthrough mRNAs are similar, but differ from PIV5-514 
CPI+.Thus there is a greater decrease in the relative abundance of the P/V/I mRNAs 515 
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compared to NP for PIV5-CPI+ than for either PIV5-W3(S157) or PIV5-W3(F157). 516 
These results suggest that there may be subtle differences  in the control of virus 517 
transcription and replication of different paramyxovirus strains. It will therefore be of 518 
interest to determine whether other strains of PIV2, PIV3 and MuV show similar 519 
profiles to the strains used here and what, if any, are the biological consequences of 520 
such differences. 521 
 522 
In the context of the mRNA abundance gradient, PIV3-Wash exhibited a relatively 523 
small decline in the relative abundance of the P/D/C, M, F and HN mRNAs. 524 
However, there was a dramatic decrease in the abundance of L mRNA compared to 525 
HN mRNA. In comparison, PIV2-Co, PIV5-W3 and PIV5-CPI+ exhibited a relatively 526 
large decrease in the relative abundance of P/V mRNA compared to NP mRNA, and 527 
then a gradual decline until the HN mRNA, before again showing a marked decrease 528 
in the abundance of L mRNA. MuV-Enders was similar to PIV2-Co and PIV5-W3, 529 
except that the first obvious decrease in abundance occurred between the P/V and 530 
M mRNAs. Although the reasons for the decrease in the relative abundance of L 531 
mRNA compared to HN mRNA is unclear, it may be that the much greater length of 532 
the former is a contributing factor. The generally accepted model for the stepwise 533 
reduction in mRNA abundance across the genome is that the vRdRP may disengage 534 
from the genome at a GE site, rather than continuing to transcribe downstream 535 
genes, but if it does so it must reinitiate at the Le promoter to continue transcribing. 536 
An alternative explanation is that vRdRP can disengage at any nucleotide with equal 537 
probability, with the aborted, non-polyA RNAs being very rapidly degraded (40, 41). 538 
Such a senario would also lead to an apparently stepwise mRNA abundance 539 
gradient. To determine whether this latter model fits the experimental data, a 540 
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theoretical model of the abundance of viral mRNAs was generated by assuming 541 
100% abundance at position 1 gradually decreasing to 1-2% at the last position of 542 
the genome (the percentage abundance of L mRNAs) to produce a theoretical 543 
mRNA abundance gradient line (Figure 8a). The intersection of the polyU-tract with 544 
the theoretical transcription line was then used to obtain the theoretical abundance of 545 
polyadenylated mRNAs. Interestingly, at 12 h p.i. (a time chosen to minimize any 546 
effects of differences in viral mRNA stability but at which appreciable levels of 547 
transcription had occurred), PIV3-Wash showed an experimental mRNA abundance 548 
gradient that is most similar to the theoretical model. Indeed, the relative abundance 549 
of the viral mRNAs, apart from L mRNA, was <1.8 fold different from the relative 550 
abundance of the mRNA of the gene immedately upstream. In contrast, L mRNA 551 
was >50 fold less than HN. PIV3 is a respirovirus with conserved GS and IG regions, 552 
and although difference in the GE sequences and other sequences present in the 553 
genome may influence the rates of termination and reinitiation at gene boundaries, it 554 
would be surprising if the marked decrease in L mRNA can be explained by the 555 
vRdRP disengaging with much greater frequency at the HN-L gene junction than at 556 
other gene boundaries. However, further experimental investigations will be needed 557 
to determine which of these two models are correct. For PIV2-Co, PIV5-W3 and 558 
MuV-Enders (rubulaviruses), the theoretical transcriptional profiles differed 559 
significantly from the experimental data for genes near the 3’ promoter. Thus, for 560 
PIV2-Co, the amount of V/P mRNA was significantly less than that of NP mRNA, 561 
whereas, for MuV-Enders, the equivalent step decrease in abundance was located 562 
between the V/P and M genes. Thereafter, the relative reduction in abundance of 563 
viral mRNAs fitted the theoretical model relatively well. Since the intergenic regions 564 
of orthorubulaviruses are not conserved within the genome, this suggests that 565 
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relative mRNA abundance may be determined both by specific disengagement of 566 
vRdRP at gene junctions, as has previously been suggested, as well as by 567 
degradation of non-polyA mRNAs generated as vRdRP randomly disengages from 568 
the template. However, if so, the biological consequences for orthorubulaviruses 569 
controlling mRNA abundance in this relatively more complicated manner than PIV3 570 
is not known. 571 
 572 
Because eukaryotic ribosomes do not generally recognise internal AUG initiation 573 
sites, viral protein expression can be further controlled by the generation of 574 
readthrough mRNAs, as downstream genes transcribed as polycistronic mRNAs 575 
would not be translated. In agreement with published work (42-44), PIV5-W3, PIV2-576 
Co and PIV3-Wash displayed a greater degree of readthrough at the M:F junction 577 
than other junctions. For PIV5-W3 and MuV-Enders, approximately one-third of 578 
transcripts starting from the M gene read into the F gene, whereas PIV3-Wash and 579 
PIV2-Co displayed a much higher proportion (approximately 90% to 98% 580 
respectively) of readthroughs, thereby significantly reducing the amount of F 581 
synthesised. It has been suggested that such a mechanism may have evolved in 582 
order to decrease amount of F made and thus to reduce the cytopathic effects of 583 
infection whilst maintaining the abundance of downstream mRNAs (17, 45). Our 584 
results showing that the rate of readthrough of PIV5-W3 at M:F is approximately 3-585 
fold higher compared to the other IGs agrees with those of Rassa and Parks (17), 586 
who used northern blot analysis to investigated mRNA read-through at each gene 587 
junction. They did, however, observe a slight change in the rate of readthrough of the 588 
M:F gene over time which was not observed during this study. As well as virus 589 
factors, host cell differences can also influence the generation of polycistronic 590 
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mRNAs (46), and may therefore explain the differences between our results and 591 
those of  Spriggs and Collins (47), who, using Northern blot analysis, showed that 592 
approximately equal amounts of F monocistronic and M:F readthrough mRNA were 593 
made during infection with PIV3-Wash. For MuV-Enders, we also show here that 594 
readthrough at the F:SH junction at 12h p.i. was >90%. In agreement, Takeuchi et al 595 
(34) showed that no monocistronic SH or SH-HN bi-cistronic mRNA was produced 596 
by MuV-Enders, although monocistronic HN and SH were made by other strains. 597 
However, although in our analysis we detected readthrough sequences between the 598 
SH-HN gene, as we cannot distinguish between bicistronic or any other polycistronic 599 
mRNAs, it is possible that the SH-HN reads we detected may have arisen from F-600 
SH-HN tricistronic mRNA, which were detected in high abundance by Takeuchi et al. 601 
(34).  602 
 603 
To initiate RNA synthesis at the Le promoter, the vRdRP recognises a conserved 604 
sequence at the 3’ end of the genome and a set of tandem repeats in the 605 
untranslated region of the NP gene that must be in the correct hexamer phase 606 
(reviewed in (48)). This suggests that vRdRP functionality may be controlled by 607 
sequence recognition or hexamer phasing, or both. The sequence and hexamer 608 
phasing of the GE and GS sites and the IG region in PIV2-Co, MuV-Enders, PIV3-609 
Wash, and both PIV5-W3 and PIV5-CPI+ were analysed for clues suggesting a 610 
mechanism for controlling vRdRP function at the gene junction. For PIV2 there were 611 
no obvious differences in the NP GE or the V/P GS that could account for the 612 
significant decrease in the abundance of V/P/I mRNA compared to NP mRNA. 613 
Similarly, no differences in the V/P GE or the M GS could be identified as a possible 614 
control mechanism in MuV for the significant decrease in M mRNA abundance 615 
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compared to V/P/I mRNA abundance. However, there was an A to U change in the 616 
GE of the NP gene of PIV5-W3 compared to PIV5-CPI+ that might account for the 617 
relatively greater drop in abundance of V/P mRNA to NP mRNA observed in PIV5-618 
CPI+. With regards mutations that may influence the abundance of PIV5 619 
readthrough mRNAs, it has previously been reported that mutations at position 5 in 620 
the M GE sequence, can affect the relative abundance of M:F readthrough mRNAs 621 
(18). Interestingly, the M GE sequences are identical between PIV5-W3 and PIV5-622 
CPI+ and they have similar levels of M:F readthrough mRNA. However, there are 623 
four nucleotide difference at the F GE between PIV5-W3 and PIV5-CPI+, including at 624 
position 5, that may explain the higher levels of F:SH readthrough mRNA in PIV5-625 
CPI+.  626 
 627 
There were also clear differences between PIV2-Co, PIV3-Wash, PIV5-W3 and 628 
MuV-Enders with regard the relative abundance of the P/V/I/D mRNAs produced by 629 
insertion of non-templated G residues at the editing site. For PIV2-Co and PIV5-W3, 630 
the ratio of V to P mRNAs was 3:1 and 2:1 respectively, and together they accounted 631 
for more than 94% of all transcripts generated from the P/V gene. This is in contrast 632 
to Thomas et al (49) who found that PIV5 inserted Gs at a ratio of 1:1. The ratio of 633 
the V to P mRNAs for MuV-Enders was roughly 1:1, with I mRNAs contributing 634 
approximately 5% of mRNAs generated from the P/V/I gene. In PIV3-Wash, the ratio 635 
of the P to V to D mRNAs was approximately 3:1:2. The high levels of the PIV3-636 
Wash D and V mRNA produced is surprising given that no biological function has 637 
been assigned to the encoded proteins. Although an ancestral ORF is present in the 638 
V mRNA, there are two stop codons downstream of the editing site that would result 639 
in the production of a truncated V protein that would be highly unlikely to act as an 640 
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IFN antagonism, as it does in PIV5. However, structural and biochemical analyses 641 
have demonstrated that the N-terminally common domain of P and V in PIV5, Sendai 642 
virus and measles virus contain binding sites for NP (7, 50-53), and thus it is 643 
possible that PIV3 V and D have roles in maintaining the solubility of NP0 soluble 644 
prior to encapsidation of the viral genome or antigenome, as has been suggested for 645 
PIV5 (7). Alternatively, the V protein of PIV3 may have a role in controlling viral 646 
transcription and replication, as has been demonstrated for a number of 647 
paramyxoviruses. 648 
 649 
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FIGURE LEGENDS 657 
 658 
Figure 1 659 
 660 
Optimization of a workflow to study PIV5-W3 transcription and replication by 661 
nondirectional analysis of HTS data followed by directional analysis to distinguish 662 
mRNA/antigenome reads from genome reads. In (a) and (b), coloured boxes indicate 663 
approximate gene positions and contain the names of the genes. The individual 664 
coloured vertical bars represent the coverage depth (number of reads) at each 665 
nucleotide in the reference sequence. (a) BWA alignments of the PIV5-W3 666 
transcriptome in HSF cells at 18 h p.i. analysed using polyA-selected RNA and 667 
visualised in Tablet. (b) and (c) Comparison of mRNA/antigenome and genome RNA 668 
abundance relative to total RNA after polyA selection or rRNA reduction of total cell 669 
RNA. RNA was extracted from PIV5-W3-infected A549 cells at 6, 12 and 18 h p.i., 670 
and the reads were subjected to directional analysis. (b) BWA alignments for 671 
mRNA/antigenome and genome reads at 18 h p.i. visualised in Tablet. (c) 672 
Abundance of mRNA/antigenome and genome reads at 6, 12 and 18 h p.i.  673 
 674 
Figure 2 675 
 676 
Kinetic analysis of PIV2-Co, PIV3-Wash, PIV5-W3 and MuV-Enders transcription 677 
and replication. The relative abundances of mRNA and genome reads were 678 
compared to the number of total reads at various times p.i. A549 cells were infected 679 
at an moi of 10-20 pfu per cell, and total RNA was isolated at various times p.i. 680 
Following physical removal of rRNA and mitochondrial RNA, the samples were 681 
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subjected to library preparation, sequencing and directional analysis, followed by 682 
bioinformatical removal of residual rRNA and mitochondrial reads. The bars show 683 
standard deviation values based on three experiments. 684 
 685 
Figure 3 686 
 687 
Comparison of the mRNA abundance gradients of PIV2-Co, PIV3-Wash, PIV5-W3 688 
and MuV-Enders with time p.i. The RNA samples described in Figure 2 were 689 
subjected to bioinformatic analysis to determine the percentage contribution of 690 
individual viral mRNAs to the total viral mRNA population. 691 
 692 
Figure 4 693 
 694 
Analysis of RNA editing. Relative abundance of the P, V and I mRNAs for PIV2-Co, 695 
PIV5-W3 and MuV-Enders (orthorubulaviruses), and the P, V and D mRNAs for 696 
PIV3-Wash (respiroviruses) in the RNA samples described in Figure 2. The number 697 
of reads generated from the RNA editing site was calculated using a 10 nt search 698 
string immediately upstream and downstream of the site. The number of inserted G 699 
residues in the reads overlapping the RNA editing site that generated the V, P and I 700 
mRNA transcripts was calculated, 0 and 0+3 G inserts (V or P for orthorubulaviruses 701 
and respiroviruses, respectively), 2 and 2+3 G inserts (P or D for orthorubulaviruses 702 
and respiroviruses, respectively) and 1 and 1+3 G inserts (I or V for 703 
orthorubulaviruses or respiroviruses, respectively). The bars show standard 704 
deviation values based on three independent experiments. 705 
 706 
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Figure 5 707 
 708 
Relative abundance of readthrough mRNAs compared to the average coverage of 709 
the gene immediately upstream for PIV2-Co, PIV5-W3, MuV-Enders and PIV3-710 
Wash. The average coverage of read overlapping the IG was compared to the 711 
average coverage read depth of the gene immediately upstream of the IG region. 712 
The bars show standard deviation values based on three independent experiments. 713 
 714 
Figure 6 715 
 716 
Effects of strain differences on PIV5 transcription and replication. (a) The relative 717 
abundance of PIV5-CPI+ mRNA and genome reads were compared to the number 718 
of total reads at various times p.i. in A549 cells. Total RNA was isolated, and, 719 
following physical removal of rRNA and mitochondrial RNA, were subjected to library 720 
preparation, HTS and directional read analysis, followed by bioinformatic removal of 721 
residual rRNA and mitochondrial RNA sequences. The mRNA abundance gradient 722 
(b), the relative abundance of the P, V and I mRNAs (c), and the generation of 723 
readthrough mRNAs (d) were determined from the datasets as described in Figures 724 
3, 4 and 5, respectively.  725 
 726 
Figure 7 727 
 728 
Transcriptional and replicative differences of PIV5 recombinant virus rPIV5-729 
W3:P(F157) (replacement of the serine residue at position 157 by a phenylalanine 730 
residue). (a) The relative abundance of rPIV5-W3:P(F157) mRNA and genome reads 731 
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were compared to the number of total reads at 24 h p.i. A549 cells were infected at 732 
an MOI of 10-20 PFU/cell and total cell RNA was isolated at various times p.i. rRNA 733 
and mitochondrial RNA were physically removed, the RNA was subjected to library 734 
preparation, sequencing and directional analysis, followed by bioinformatic removal 735 
of residual rRNA and mitochondrial RNA sequences. The mRNA abundance gradient 736 
(b), the relative abundance of the P, V, and I  mRNAs (c), and the generation of read-737 
through mRNAs (d) was determined from the datasets as described in Figures 3, 4 738 
and 5, respectively. 739 
 740 
Figure 8 741 
 742 
Theoretical mRNA abundance gradients compared to actual gradients in a model in 743 
which vRdRP disengages with equal chance at any nucleotide during transcription, 744 
and truncated, non-polyA mRNAs are rapidly degraded. (a) Model of the relative 745 
abundance of individual viral mRNAs in which position 1 of the genome constitutes 746 
100% of transcripts and the last nucleotide constitutes 1-2%. The end of each gene 747 
is indicated where polyadenylation occurs at the U-tract to generate mRNAs that are 748 
subsequently translated. In this model it assumes that transcripts that are 749 
prematurely terminated when vRdRP disengages from the genome upstream of the 750 
U-tract are not polyadenylated and are degraded rapidly. The step-wise transcription 751 
profiles therefore reflect the theoretical abundance of polyadenylated mRNAs. (b) 752 
The theoretical percentage contribution of polyadenylated viral mRNAs to the total 753 
viral mRNA population, as calculated from the theoretical gradient shown in (a). (c) 754 
The mRNA abundance gradient determined experimentally for cells infected with 755 
PIV2-Co, PIV5-W3, MuV or PIV3-Wash at 12 h p.i. as described in Figure 2. 756 
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Table 1. Percentages of PIV5 strain W3 viral mRNA reads compared to total reads 757 
before and after rRNA and mitochondrial RNA reads had been bioinformatically 758 
removed from the data obtained using polyA selection or rRNA reduction library 759 
preparation. 760 
 761 
 
Before reads 
removed  
Reads in datasets 
 
After reads removed 
 
polyA selection 
h p.i mRNA 
 
rRNA mitochondrial 
 
mRNA 
6 1.5 
 
1.6 8.5 
 
1.6 
12 8.2 
 
1.6 6.1 
 
8.9 
18 5.4 
 
3.1 7.3 
 
5.9 
 
rRNA reduction 
6 1.0 
 
0.4 3.8 
 
1.1 
12 7.2 
 
0.2 11.8 
 
8.2 
18 4.8 
 
1.9 13.2 
 
5.6 
  762 
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Table 2. Mean percentages of reads containing additional inserted G residues 763 
compared with total number of reads overlapping the V/P RNA editing site. 764 
 765 
  
number of additional inserted G residues 
 
h p.i. 0 1 2 3 4 5 6 7 
 PIV2-Co 6 74% 0% 25% 1% 0.0% 0.0% 0.0% 0.0% 
 
12 76% 1% 22% 1% 0.1% 0.0% 0.0% 0.0% 
 
18 76% 1% 22% 1% 0.1% 0.0% 0.0% 0.0% 
 
24 77% 1% 21% 1% 0.1% 0.0% 0.0% 0.0% 
PIV5-W3 6 64% 2% 29% 2% 1% 2% 0.0% 0.0% 
 
12 60% 2% 33% 2% 2% 1% 0.1% 0.0% 
 
18 59% 1% 35% 3% 1% 1% 0.1% 0.0% 
 
24 62% 1% 33% 2% 1% 0% 0.1% 0.0% 
MuV Enders 6 41% 6% 44% 5% 4% 1% 0.2% 0.1% 
 
12 46% 5% 39% 6% 4% 1% 0.0% 0.0% 
 
18 47% 4% 38% 6% 4% 1% 0.1% 0.0% 
 
24 48% 5% 39% 5% 3% 0.4% 0.1% 0.0% 
PIV3-Wash 6 47% 24% 8% 7% 6% 7% 0.6% 0.2% 
 
12 39% 27% 10% 7% 10% 7% 0.5% 0.3% 
 
18 40% 26% 10% 7% 10% 7% 0.6% 0.2% 
 
24 41% 24% 10% 8% 9% 8% 0.8% 0.4% 
 766 
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